News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KV Pharmaceutical Protests Hologic, Inc. (HOLX) Bid to Reacquire Drug



9/24/2012 7:49:49 AM

K-V Pharmaceutical (KVPBQ) is protesting drug maker Hologic Inc.'s (HOLX) "brazen" attempt to circumvent bankruptcy law to get its hands on the rights to Makena, a drug that reduces the risk of premature births. K-V Pharmaceutical, which filed for bankruptcy last month, said in a court filing Thursday night that Hologic is trying to derail its restructuring efforts in order to reacquire the worldwide rights to Makena. The premature birth drug is crucial to K-V's business and reorganization efforts. "Without Makena, the debtors will have no prospects for a successful restructuring," K-V's lawyers said in a filing in U.S. Bankruptcy court in New York.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES